A Phase 2 Trial of ALIMTA (Pemetrexed) in Locally Advanced or Metastatic Recurrent Transitional Cell Carcinoma of the Urothelium

Completed · Phase 2

Conditions studied: Urologic Neoplasms, Metastases, Neoplasm

In brief

Patients with bladder cancer will be participating in this study for the treatment of abnormal cells in the bladder that have returned after initial treatment OR have moved to a new site in the body.

Key facts

Study ID

NCT00035061

Run by

Eli Lilly and Company

Last updated by the study team

2006-07-19

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• You must have been diagnosed with bladder cancer that has recurred or moved to a new part of the body.
• You must have at least one tumor that can be physically measured or scanned by x-ray.
• You may not have had previous chemotherapy (drug) treatment OR you have had surgery followed by one chemotherapy treatment at least 4 months ago.

You may not qualify if…

• You may not have used an experimental medicine or device within the past month.
• Cancer that has spread to your brain.
• If you are unwilling or unable to take folic acid or vitamin B12 supplements.

Where it is running

• Study site — Los Angeles, California, United States
• Study site — Palo Alto, California, United States
• Study site — Boca Raton, Florida, United States
• Study site — Tampa, Florida, United States
• Study site — Decatur, Illinois, United States
• Study site — Indianapolis, Indiana, United States
• Study site — Lafayette, Indiana, United States
• Study site — Muncie, Indiana, United States
• Study site — South Bend, Indiana, United States
• Study site — Lenexa, Kansas, United States
• Study site — Saint Mathews, Kentucky, United States
• Study site — Boston, Massachusetts, United States
• Study site — Omaha, Nebraska, United States
• Study site — Cleveland, Ohio, United States
• Study site — Philadelphia, Pennsylvania, United States
• Study site — Pittsburgh, Pennsylvania, United States
• Study site — Nashville, Tennessee, United States
• Study site — Fort Worth, Texas, United States
• Study site — Houston, Texas, United States
• Study site — Seattle, Washington, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.